This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2015-2017.
Location History:
- Madison, WI (US) (2015 - 2016)
- Melrose, MA (US) (2017)
Company Filing History:
Years Active: 2015-2017
Title: Michael Palte: Innovator in Boron Chemistry and HIV Research
Introduction
Michael Palte is a distinguished inventor based in Madison, WI (US). He has made significant contributions to the field of chemistry, particularly in the development of boron-based compounds for medical applications. With a total of 3 patents, his work focuses on enhancing the treatment and prevention of HIV.
Latest Patents
Palte's latest patents include innovative methods and compounds aimed at combating HIV. One notable patent is for "Boronic acid inhibitors of HIV protease," which details protease inhibitors that are boronated to enhance their activity and cellular entry. This invention includes compounds, prodrugs, and salts that contain phenylboronate groups, specifically designed to treat AIDS and ARC, as well as to prevent HIV infection. Another significant patent is for "Boronate-mediated delivery of molecules into cells," which outlines methods for improving the cellular uptake of cargo molecules through boronation. This technique involves bonding phenylboronic acids to cargo molecules, facilitating their introduction into cells.
Career Highlights
Michael Palte is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance his research in boron chemistry. His innovative approaches have the potential to significantly impact the treatment of HIV and related conditions.
Collaborations
Palte has collaborated with notable researchers, including Ronald Thaddeus Raines and Ian Windsor, to further his work in the field. These collaborations have enriched his research and contributed to the development of his patented technologies.
Conclusion
Michael Palte's contributions to boron chemistry and HIV research exemplify the impact of innovative thinking in addressing critical health challenges. His patents reflect a commitment to advancing medical science and improving patient outcomes.